260 related articles for article (PubMed ID: 31058792)
1. Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
Tokatly Latzer I; Nahum E; Cavari Y; Lazar I; Ben-Ari Y; Ben-Shimol S; Ben-Shalom G; Geffen Y; Goldberg L; Rubinstein M; Keller N; Pessach IM; Paret G
Pediatr Crit Care Med; 2019 May; 20(5):e231-e239. PubMed ID: 31058792
[TBL] [Abstract][Full Text] [Related]
2. Management of Stenotrophomonas maltophilia Infections in Critically Ill Children.
Tokatly Latzer I; Paret G; Rubinstein M; Keller N; Barkai G; Pessach IM
Pediatr Infect Dis J; 2018 Oct; 37(10):981-986. PubMed ID: 29634621
[TBL] [Abstract][Full Text] [Related]
3. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
Alsuhaibani M; Aljarbou A; Althawadi S; Alsweed A; Al-Hajjar S
Antimicrob Resist Infect Control; 2021 Jan; 10(1):19. PubMed ID: 33482916
[TBL] [Abstract][Full Text] [Related]
4. Clinical Characteristics of Stenotrophomonas maltophilia Bacteremia: A Regional Report and a Review of a Japanese Case Series.
Ebara H; Hagiya H; Haruki Y; Kondo E; Otsuka F
Intern Med; 2017; 56(2):137-142. PubMed ID: 28090041
[TBL] [Abstract][Full Text] [Related]
5. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
Wang CH; Lin JC; Lin HA; Chang FY; Wang NC; Chiu SK; Lin TY; Yang YS; Kan LP; Yang CH; Chan MC; Yeh KM
J Microbiol Immunol Infect; 2016 Jun; 49(3):378-86. PubMed ID: 25081988
[TBL] [Abstract][Full Text] [Related]
6. Clinical Features, Outcomes, and Risk Factors of Bloodstream Infections due to
Chen Y; Suo J; Du M; Chen L; Liu Y; Wang L; Liang Z
Biomed Res Int; 2019; 2019():4931501. PubMed ID: 31886220
[No Abstract] [Full Text] [Related]
7. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for death from Stenotrophomonas maltophilia bacteremia.
Osawa K; Shigemura K; Kitagawa K; Tokimatsu I; Fujisawa M
J Infect Chemother; 2018 Aug; 24(8):632-636. PubMed ID: 29673561
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis.
Ko JH; Kang CI; Cornejo-Juárez P; Yeh KM; Wang CH; Cho SY; Gözel MG; Kim SH; Hsueh PR; Sekiya N; Matsumura Y; Lee DG; Cho SY; Shiratori S; Kim YJ; Chung DR; Peck KR
Clin Microbiol Infect; 2019 May; 25(5):546-554. PubMed ID: 30448331
[TBL] [Abstract][Full Text] [Related]
10. Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.
Hand E; Davis H; Kim T; Duhon B
J Antimicrob Chemother; 2016 Apr; 71(4):1071-5. PubMed ID: 26801080
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology and characteristics of 16 cases with Stenotrophomonas maltophilia bacteraemia in pediatric Intensive Care Units.
Motamedifar M; Heidari H; Yasemi M; Sedigh Ebrahim-Saraie H
Ann Ig; 2017; 29(4):264-272. PubMed ID: 28569336
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
Kim SH; Cho SY; Kang CI; Seok H; Huh K; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Ann Hematol; 2018 Feb; 97(2):343-350. PubMed ID: 29138886
[TBL] [Abstract][Full Text] [Related]
13. Stenotrophomonas maltophilia bacteremia in pediatric patients-- a 10-year analysis.
Wu PS; Lu CY; Chang LY; Hsueh PR; Lee PI; Chen JM; Lee CY; Chan PC; Chang PY; Yang TT; Huang LM
J Microbiol Immunol Infect; 2006 Apr; 39(2):144-9. PubMed ID: 16604247
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of Stenotrophomonas maltophilia bacteremia in children.
Furuichi M; Ito K; Miyairi I
Pediatr Int; 2016 Feb; 58(2):113-8. PubMed ID: 26139084
[TBL] [Abstract][Full Text] [Related]
15. Sulfamethoxazole/trimethoprim versus fluoroquinolones for the treatment of Stenotrophomonas maltophilia bloodstream infections.
Watson L; Esterly J; Jensen AO; Postelnick M; Aguirre A; McLaughlin M
J Glob Antimicrob Resist; 2018 Mar; 12():104-106. PubMed ID: 28964955
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim/Sulfamethoxazole vs Minocycline for the Treatment of Nonurinary Monomicrobial
Hevia EC; Wooten L; Carr AL
Ann Pharmacother; 2024 Jul; 58(7):698-704. PubMed ID: 37776160
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
Lai CH; Chi CY; Chen HP; Chen TL; Lai CJ; Fung CP; Yu KW; Wong WW; Liu CY
J Microbiol Immunol Infect; 2004 Dec; 37(6):350-8. PubMed ID: 15599467
[TBL] [Abstract][Full Text] [Related]
18. Stenotrophomonas maltophilia infection among young children in a cardiac intensive care unit: a single institution experience.
Arthur C; Tang X; Romero JR; Gossett JG; Harik N; Prodhan P
Pediatr Cardiol; 2015 Mar; 36(3):509-15. PubMed ID: 25293429
[TBL] [Abstract][Full Text] [Related]
19. Stenotrophomonas maltophilia bacteraemia in Turkish children.
Güriz H; Ciftçi E; Ayberkin E; Aysev D; Ince E; Arsan S; Yavuz G; Doğru U
Ann Trop Paediatr; 2008 Jun; 28(2):129-36. PubMed ID: 18510823
[TBL] [Abstract][Full Text] [Related]
20. Stenotrophomonas maltophilia bacteremia in children - A 10-year analysis.
Büyükcam A; Bıçakcıgil A; Cengiz AB; Sancak B; Ceyhan M; Kara A
Arch Argent Pediatr; 2020 Jun; 118(3):e317-e323. PubMed ID: 32470274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
